AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Stavudine in South Africa

12 products registered with SAHPRA — 4 active

Brand / ProductReg. No.HolderStatusExpires
SONKE-STAVUDINE 30A40/20.2.8/0421Ranbaxy (SA) (Pty) Ltdsuspended30 Jun 2024
SONKE-STAVUDINE 40A40/20.2.8/0422Ranbaxy (SA) (Pty) Ltdsuspended30 Jun 2024
DYNAVIR CAPSULES 20 mg41/20.2.8/0811Aurogen South Africa (Pty) Ltdsuspended10 Nov 2022
DYNAVIR CAPSULES 40 mg42/20.2.8/1012Aurogen South Africa (Pty) Ltdsuspended10 Nov 2022
DYNAVIR CAPSULES 15 mg41/20.2.8/0810Aurogen South Africa (Pty) Ltdsuspended10 Nov 2022
DYNAVIR CAPSULES 30 mg42/20.2.8/1011Aurogen South Africa (Pty) Ltdsuspended10 Nov 2022
VARI-STAVUDINE 30 mgA39/20.2.8/0110Specpharm (Pty) Ltdsuspended3 Nov 2022
DYNAVIR POWDER FOR ORAL SOLUTION 1 mg/ml43/20.2.8/0565Aurobindo Pharma (Pty) Ltdsuspended22 Sept 2022
ASPEN STAVUDINE 20 mg37/20.2.8/0111Pharmacare Limited û Woodmeadactive1 Jan 1900
ASPEN STAVUDINE 30 mg37/20.2.8/0112Pharmacare Limited û Woodmeadactive1 Jan 1900
ASPEN STAVUDINE 40 mg37/20.2.8/0113Pharmacare Limited û Woodmeadactive1 Jan 1900
ASPEN STAVUDINE 15 mg37/20.2.8/0110Pharmacare Limited û Woodmeadactive1 Jan 1900

Stavudine — SAHPRA Registration Details

SAHPRA (South Africa) has 12 registered products containing Stavudine, of which 4 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Stavudine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.